SF
LVGO

Synovus Financial’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Synovus Financial’s Portfolio LVGO Stock Details LVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-135
Closed -$10K – 1602
2020
Q2 		$10K Buy
+135
New +$7.07K ﹤0.01% 1225

Other funds holding LVGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Synovus Financial's LVGO Position: Q3 2020 in Review

Synovus Financial sold out of Livongo Health, Inc. Common Stock (LVGO) in Q3 2020, closing a stake of 135 shares — an estimated $10K sold.

Synovus Financial first reported a position in LVGO in Q2 2020 and held it in 1 quarter. The position peaked at $10K in Q2 2020. 391 funds tracked by Wall St. Rank hold LVGO as of Q3 2020.

  • Synovus Financial reported no remaining Livongo Health, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Synovus Financial sold 135 Livongo Health, Inc. Common Stock shares in Q3 2020, an estimated $10K.
  • Synovus Financial first reported a position in Livongo Health, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Synovus Financial's Livongo Health, Inc. Common Stock position peaked at $10K in Q2 2020.
  • 391 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.